|
1 Indications And Usage Aggrastat® Is Indicated To Reduce The Rate Of Thrombotic Cardiovascular Events (Combined Endpoint Of Death, Myocardial Infarction, Or Refractory Ischemia/repeat Cardiac Procedure) In Patients With Non-St Elevation Acute Coronary Syndrome (Nste-Acs). Aggrastat Is A Platelet Aggregation Inhibitor Indicated To Reduce The Rate Of Thrombotic Cardiovascular Events (Combined Endpoint Of Death, Myocardial Infarction, Or Refractory Ischemia/repeat Cardiac Procedure) In Patients With Non-St Elevation Acute Coronary Syndrome (Nste-Acs).
|